Percutaneous image-guided treatment of aneurysmal bone cysts: is there a superior treatment option?

• Published in: Pediatric radiology 2022-07, Vol.52 (8), p.1539-1549
• Main Authors: Arleo, Timothy L., Hawkins, C. Matthew, Fabregas, Jorge A., Gill, Anne E.
• Format: Article
• Language: English
• Subjects: Ablation; Aneurysm; Antibiotics; Bone surgery; Computed tomography; Curettage; Cysts; Doxycycline; Fractures; Imaging; Magnetic resonance imaging; Medical imaging; Medicine; Medicine & Public Health; Neuroradiology; Nuclear Medicine; Oncology; Original Article; Orthopedics; Pain; Patients; Pediatrics; Radiology; Sclerotherapy; Side effects; Surgery; Ultrasound
• ISSN: 0301-0449; 1432-1998
• DOI: 10.1007/s00247-022-05326-6

Background Aneurysmal bone cysts (ABCs) are often treated with intralesional surgery (curettage) with or without adjuvant treatments. Side effects and conflicting results regarding recurrence rates do not suggest one clearly superior therapy. Percutaneous therapeutic options including sclerotherapy and thermal ablation have gained popularity as potential alternatives. Objective The purpose of this retrospective review is to report this institution’s experience and results of various image-guided minimally invasive treatments in a single institution series of cases referred to interventional radiology by orthopedic surgery after surgical failure or in patients with anatomically challenging ABCs. Materials and methods This study identified all patients ≤18 years old who received percutaneous therapy for an ABC, including cryoablation, doxycycline sclerotherapy, microwave ablation or a combination of these modalities. Procedural details, complications, imaging follow-up and clinical follow-up were analyzed. Results A total of 21 patients received 41 procedures, with major complications seen in 7.7% (3/39) of procedures involving cryoablation or doxycycline sclerotherapy. Patients receiving cryoablation required an average of 1.7 procedures (median: 1 procedure, range: 1–4 procedures) while patients receiving doxycycline sclerotherapy required an average of 3 procedures (median: 2 procedures, range: 1–6 procedures). Patients were followed clinically and with computed tomography or magnetic resonance imaging (average: 23.9 months, range: 3.9–68.3 months). Follow-up imaging demonstrated improvement in 17 (85%) patients. Clinically, 93.8% (15/16) of patients who presented with fracture or pain had markedly reduced or absent pain as well as no fractures. Conclusion Percutaneous image-guided treatment of ABCs demonstrates a favorable efficacy and safety profile. Adding cryoablation may lead to fewer total procedures than using doxycycline sclerotherapy alone.